Beiersdorf Faces Growth Challenges as RBC Capital Markets Slashes Price Target Amidst Rising Competition and Cost Pressures

The financial outlook for Beiersdorf (ETR: BEIG) appears to be facing significant hurdles, as analysts from RBC Capital Markets expressed skepticism regarding the company's ambitious sales growth targets. In their latest assessment, RBC deemed Beiersdorf's expectation of achieving an organic sales growth rate of 4-6% for the year as "unrealistically challenging."

RBC's analysts highlighted a particularly daunting second half ahead, noting that the anticipated acceleration in growth seems unlikely due to an unpredictable consumer landscape and intensified competition. Their projections suggest that Beiersdorf's organic sales growth may only reach 3.9% in 2025, which is considerably below industry expectations. Similarly cautious forecasts were set for 2026 and 2027, with predicted growth rates of 5.1% and 4.2%, trailing consensus estimates of 5.9% and 5.5% respectively.

Compounding Beiersdorf's challenges is the pressure on its flagship brand, Nivea, especially within the facial care segment. The brand has lost ground in critical markets including the U.S., China, and Germany. Although new product launches, such as the premium-priced Epicelline anti-aging line, are on the horizon, RBC casts doubts on their potential to significantly enhance growth, citing possible cannibalization of existing products and concerns regarding affordability in a price-sensitive market.

The analysts also flagged rising cost pressures, prompting a revision of EBIT margin forecasts downward. They now expect a margin improvement of only 40 basis points for 2025, a decrease from the previously projected 50 basis points. Additionally, 2026 is anticipated to see no margin improvement, with only modest recovery expected by 2027. By that time, RBC's adjusted EBIT forecast is projected to be 9% lower than what consensus estimates suggest.

Beiersdorf's premium brand, La Prairie, isn't immune to these challenges, facing scrutiny due to its high pricing-sometimes exceeding competitors by up to 1,070% in select categories-especially in an environment with waning consumer sentiment. RBC does not foresee a swift recovery for this segment either.

Despite the pessimistic growth outlook, RBC retained its Sector Perform rating for Beiersdorf, given that the company's share price has lagged behind both the broader consumer staples sector and its main rival, L'Oréal, by around 20% year-to-date. Currently, the stock is trading at a 2026E EV/NOPAT multiple of 17x, which RBC considers fairly reasonable given the company's cash reserves.

In light of these developments, RBC has revised its 12-month price target downwards to €107 from €120, with their Adjusted Present Value model suggesting a fair value of around €101 per share based on a 7% cost of equity and a terminal growth rate of 2.5%. They estimate free cash flow will increase to €854 million by 2027, compared to €785 million in 2024, indicating a FCF yield improvement to 3.6%.

RBC analysts emphasized the importance of robust marketing investment, urging management against the temptation to curb marketing expenses to preserve profitability, warning that such a move could adversely affect long-term growth prospects. As Beiersdorf navigates through these challenging waters, traders should remain vigilant and consider the wider market implications of these forecasts.